Sonen Capital LLC Sells 578 Shares of The Cooper Companies, Inc. (NYSE:COO)

Sonen Capital LLC decreased its position in shares of The Cooper Companies, Inc. (NYSE:COOGet Rating) by 15.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,189 shares of the medical device company’s stock after selling 578 shares during the quarter. Cooper Companies accounts for approximately 1.6% of Sonen Capital LLC’s investment portfolio, making the stock its 17th largest position. Sonen Capital LLC’s holdings in Cooper Companies were worth $1,332,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. MAI Capital Management lifted its holdings in shares of Cooper Companies by 0.9% in the fourth quarter. MAI Capital Management now owns 3,236 shares of the medical device company’s stock worth $1,356,000 after acquiring an additional 28 shares during the last quarter. Whittier Trust Co. of Nevada Inc. increased its stake in shares of Cooper Companies by 12.9% in the first quarter. Whittier Trust Co. of Nevada Inc. now owns 263 shares of the medical device company’s stock valued at $110,000 after buying an additional 30 shares during the period. Harel Insurance Investments & Financial Services Ltd. increased its stake in shares of Cooper Companies by 56.5% in the fourth quarter. Harel Insurance Investments & Financial Services Ltd. now owns 97 shares of the medical device company’s stock valued at $41,000 after buying an additional 35 shares during the period. Koshinski Asset Management Inc. increased its stake in shares of Cooper Companies by 17.0% in the first quarter. Koshinski Asset Management Inc. now owns 248 shares of the medical device company’s stock valued at $104,000 after buying an additional 36 shares during the period. Finally, Greenleaf Trust increased its position in Cooper Companies by 6.5% during the 1st quarter. Greenleaf Trust now owns 591 shares of the medical device company’s stock valued at $247,000 after purchasing an additional 36 shares during the period. Institutional investors own 98.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on COO. Citigroup raised their price objective on shares of Cooper Companies from $405.00 to $406.00 and gave the stock a “buy” rating in a research report on Monday, June 6th. Stifel Nicolaus cut their target price on Cooper Companies from $475.00 to $450.00 in a report on Monday, June 6th. Piper Sandler cut their target price on Cooper Companies from $425.00 to $375.00 and set an “overweight” rating on the stock in a report on Friday, July 8th. Stephens cut their target price on Cooper Companies from $500.00 to $460.00 and set an “overweight” rating on the stock in a report on Friday, June 3rd. Finally, KeyCorp reduced their price objective on shares of Cooper Companies from $414.00 to $408.00 and set an “overweight” rating for the company in a research report on Friday, June 3rd. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $426.78.

Cooper Companies Stock Up 1.1 %

COO stock traded up $3.44 on Friday, reaching $330.91. 147,690 shares of the company traded hands, compared to its average volume of 267,113. The Cooper Companies, Inc. has a one year low of $284.01 and a one year high of $463.59. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.05 and a quick ratio of 0.69. The company has a market cap of $16.33 billion, a P/E ratio of 17.38, a price-to-earnings-growth ratio of 2.49 and a beta of 0.90. The firm has a fifty day simple moving average of $319.08 and a 200-day simple moving average of $363.62.

Cooper Companies (NYSE:COOGet Rating) last posted its earnings results on Thursday, June 2nd. The medical device company reported $3.24 EPS for the quarter, missing analysts’ consensus estimates of $3.41 by ($0.17). The business had revenue of $829.80 million during the quarter, compared to the consensus estimate of $821.03 million. Cooper Companies had a return on equity of 9.48% and a net margin of 30.20%. The firm’s revenue for the quarter was up 15.3% on a year-over-year basis. During the same period in the previous year, the business posted $3.38 EPS. Research analysts anticipate that The Cooper Companies, Inc. will post 13.17 earnings per share for the current year.

Cooper Companies Dividend Announcement

The company also recently declared a semi-annual dividend, which will be paid on Thursday, August 11th. Stockholders of record on Wednesday, July 27th will be paid a $0.03 dividend. The ex-dividend date is Tuesday, July 26th. Cooper Companies’s dividend payout ratio (DPR) is currently 0.32%.

Cooper Companies Company Profile

(Get Rating)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Articles

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NYSE:COOGet Rating).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.